Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSPIRE-FLO: iEPO vs iNO in Heart and Lung Transplantation
NCT03081052Phase 4Completed
- Sponsor
- Duke University
- Start
- May 2017
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in pulmonary hypertension (PH), right-sided heart failure, sponsored by Duke University. Started May 2017; status: completed.
02
Drugs
epoprostenol
03
Conditions
pulmonary hypertension (PH)right-sided heart failure
Beyond the preview
Go deeper on NCT03081052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03081052.